We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+25.21%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$13.9M
AUM Growth
-$44.5M
Cap. Flow
-$44.7M
Cap. Flow %
-320.95%
Top 10 Hldgs %
48.07%
Holding
80
New
14
Increased
3
Reduced
23
Closed
39

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$510K
2
ELV icon
Elevance Health
ELV
+$459K
3
HUM icon
Humana
HUM
+$427K
4
CNC icon
Centene
CNC
+$371K
5
PFE icon
Pfizer
PFE
+$281K

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$2.23M
2
MCHP icon
Microchip Technology
MCHP
+$2.23M
3
ZBH icon
Zimmer Biomet
ZBH
+$1.99M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.81M
5
TWLO icon
Twilio
TWLO
+$1.74M

Sector Composition

Rank Sector Weight
1 Healthcare 99.1%
2 Miscellaneous 0.9%
3 Communication Services 0%
4 Consumer Discretionary 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMMU
26
DELISTED
Immunomedics Inc
IMMU
$230K 1.65%
+10,880
New +$192K
ABT icon
27
Abbott
ABT
$195B
$223K 1.6%
+2,565
New +$215K
MOH icon
28
Molina Healthcare
MOH
$10.4B
$188K 1.35%
1,387
-5,796
-81% -$730K
EW icon
29
Edwards Lifesciences
EW
$52B
$184K 1.32%
2,364
-8,793
-79% -$687K
LAB icon
30
Standard BioTools
LAB
$252M
$132K 0.95%
37,856
+2,504
+7% +$8.81K
CTLT
31
DELISTED
CATALENT, INC.
CTLT
$126K 0.9%
2,231
-11,331
-84% -$578K
ABBV icon
32
AbbVie
ABBV
$451B
$112K 0.8%
+1,269
New +$105K
AXNX
33
DELISTED
Axonics, Inc. Common Stock
AXNX
$110K 0.79%
3,978
+2,041
+105% +$48.7K
CSII
34
DELISTED
Cardiovascular Systems, Inc.
CSII
$96K 0.69%
1,985
-3,930
-66% -$179K
VRTX icon
35
Vertex Pharmaceuticals
VRTX
$137B
$95K 0.68%
+434
New +$87.8K
HALO icon
36
Halozyme
HALO
$12B
$82K 0.59%
+4,650
New +$80.5K
AMRN
37
Amarin Corp
AMRN
$295M
$81K 0.58%
+188
New +$71.4K
CHRS icon
38
Coherus Oncology
CHRS
$218M
$68K 0.49%
3,771
-4,035
-52% -$74.4K
ACOR
39
DELISTED
Acorda Therapeutics
ACOR
$37K 0.27%
153
-13
-8% -$3.28K
ELGX
40
DELISTED
Endologix Inc
ELGX
$4K 0.03%
2,440
-442
-15% -$1.24K
AMD icon
41
Advanced Micro Devices
AMD
$760B
– –
-25,859
Closed -$750K
BABA icon
42
Alibaba
BABA
$296B
– –
-2,532
Closed -$423K
CRM icon
43
Salesforce
CRM
$211B
– –
-10,032
Closed -$1.49M
DXCM icon
44
DexCom
DXCM
$34.3B
– –
-21,292
Closed -$794K
EQ icon
45
Equillium
EQ
$152M
– –
-5,333
Closed -$20K
FATE icon
46
Fate Therapeutics
FATE
$291M
– –
-8,899
Closed -$138K
GDDY icon
47
GoDaddy
GDDY
$12.4B
– –
-21,910
Closed -$1.45M
GS icon
48
Goldman Sachs
GS
$301B
– –
-1,562
Closed -$324K
INSP icon
49
Inspire Medical Systems
INSP
$1.78B
– –
-3,549
Closed -$217K
INTU icon
50
Intuit
INTU
$97.9B
– –
-5,722
Closed -$1.52M
1
2
3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, Partner Investment Management held 80 positions worth $13.9M, down 76% from $58.4M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Partner Investment Management withdrew a net $44.7M in Q4 2019, closing 39 positions and reducing 23 holdings. Its most notable exit was NXP Semiconductors, an estimated $2.23M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 53% a quarter earlier, followed by Miscellaneous and Communication Services.

Against the trend, Partner Investment Management opened a new position in Biogen worth $546K.

  • Partner Investment Management's largest Q4 2019 buy was Biogen: 1,839 shares worth $546K.
  • Partner Investment Management added most to Axonics, Inc. Common Stock in Q4 2019, an estimated $48.7K increase.
  • Partner Investment Management's biggest Q4 2019 reduction was Zimmer Biomet, cutting an estimated $1.99M.
  • Partner Investment Management fully exited NXP Semiconductors in Q4 2019, selling an estimated $2.23M.
  • Partner Investment Management's ten largest holdings make up 48% of its $13.9M portfolio in Q4 2019.
  • Partner Investment Management opened 14 new positions and closed 39 in Q4 2019.
  • Partner Investment Management's portfolio value fell 76% quarter-over-quarter to $13.9M.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.